Abstract
It is very clear that RNA interference (RNAi) is a potent and versatile tool for gene silencing. One of the hurdles to making siRNA/miRNA a human therapeutic includes effective in vivo delivery and being able to deliver drugs to target cells only. The commercial success of in vivo applications of RNAi hinges on the development of new delivery methods. Our strategy involves the use of antibody-based delivery agents to target and deliver siRNA into specific cell types. We have developed antibody-based agents for directed delivery into cultured cells and animal disease models. Using antibodies against various cell surface receptors, modified siRNAs are attached to antibody complexes using RNA carrier proteins. The complex can then be intravenously administered to in vivo models and taken up by specific cells via receptor-mediated endocytosis. The labile structure of the linking agents enables release of siRNA molecules post internalization. Using this targeting strategy, we have developed a method that allows any commercially available or recombinant antibody to be conjugated to siRNA for delivery purposes.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Tuschl, T., Zamore, P. D., Lehmann, R., Bartel, D. P., and Sharp, P. A. (1999) Targeted mRNA degradation by double-stranded RNA in vitro. Genes Dev 13, 3191–3197.
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., et al. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494–498.
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., et al. (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806–811.
Nguyen, T., Menocal, E. M., Harborth, J., and Fruehauf, J. H. (2008) RNAi therapeutics: an update on delivery. Curr Opin Mol Ther 10, 158–167.
Rossi, J. J. (2005) Receptor-targeted siRNAs. Nat Biotechnol 23, 682–684.
Dykxhoorn, D. M., and Lieberman, J. (2006) Silencing viral infection. PLoS Med 3, e242.
Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., et al. (2004) Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432, 173–178.
McCaffrey, A. P., Nakai, H., Pandey, K., Huang, Z., Salazar, F. H., et al. (2003) Inhibition of hepatitis B virus in mice by RNA interference. Nat Biotechnol 21, 639–644.
Lasic, D. D., Vallner, J. J., and Working, P. K. (1999) Sterically stabilized liposomes in cancer therapy and gene delivery. Curr Opin Mol Ther 1, 177–185.
Cho, W. G., Albuquerque, R. J., Kleinman, M. E., Tarallo, V., Greco, A., et al. (2009) Small interfering RNA-induced TLR3 activation inhibits blood and lymphatic vessel growth. Proc Natl Acad Sci USA 106, 7137–7142.
Kariko, K., Bhuyan, P., Capodici, J., Ni, H., Lubinski, J., et al. (2004) Exogenous siRNA mediates sequence-independent gene suppression by signaling through toll-like receptor 3. Cells Tissues Organs 177, 132–138.
Song, E., Zhu, P., Lee, S. K., Chowdhury, D., Kussman, S., et al. (2005) Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat Biotechnol 23, 709–717.
Peer, D., Zhu, P., Carman, C. V., Lieberman, J., and Shimaoka, M. (2007) Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1. Proc Natl Acad Sci USA 104, 4095–4100.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Toloue, M.M., Ford, L.P. (2011). Antibody Targeted siRNA Delivery. In: Goodchild, J. (eds) Therapeutic Oligonucleotides. Methods in Molecular Biology, vol 764. Humana Press. https://doi.org/10.1007/978-1-61779-188-8_8
Download citation
DOI: https://doi.org/10.1007/978-1-61779-188-8_8
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-187-1
Online ISBN: 978-1-61779-188-8
eBook Packages: Springer Protocols